GENM
4715
GENTING
3182
CIMB
1023
4
MAYBANK
1155
5
KOPI
0338
MY Stock MarketDetailed Quotes
5288 SIMEPROP
- 1.400
- -0.070-4.76%
15min DelayMarket Closed Feb 28 16:59 CST
9.52BMarket Cap18.92P/E (TTM)
1.450High1.390Low24.57MVolume1.440Open1.470Pre Close34.77MTurnover1.81052wk High0.37%Turnover Ratio6.80BShares0.71152wk Low0.074EPS TTM9.42BFloat Cap1.810Historical High18.92P/E (Static)6.73BShs Float0.372Historical Low0.074EPS LYR4.08%Amplitude0.03Dividend TTM0.93P/B100Lot Size2.14%Div YieldTTM
SIMEPROP Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.68%4.25B | -3.52%977.04M | 3.99%1.09B | 74.65%1.2B | 42.81%978.69M | 25.34%3.44B | 5.83%1.01B | 52.33%1.05B | 11.91%688.92M | 42.68%685.33M |
| Cost of revenue | 19.21%2.89B | -5.30%697.52M | 6.22%750.84M | 53.49%770.86M | 39.96%675.09M | 26.75%2.43B | 11.20%736.54M | 46.72%706.89M | 18.35%502.23M | 38.97%482.34M |
| Gross profit | 34.44%1.36B | 1.22%279.52M | -0.60%341.04M | 131.58%432.32M | 49.56%303.61M | 22.06%1.01B | -6.25%276.16M | 65.35%343.11M | -2.39%186.69M | 52.35%203M |
| Operating expense | 13.46%456.73M | -28.89%109.29M | 61.50%143.73M | 37.34%96.68M | 19.65%107.03M | 18.32%402.53M | 37.96%153.69M | 4.23%88.99M | -14.44%70.39M | 46.28%89.45M |
| Selling and administrative expenses | 24.94%490.66M | 13.25%139.32M | 49.96%143.22M | 17.95%100.01M | 20.92%108.11M | 8.76%392.72M | 0.72%123.02M | 10.88%95.5M | -5.88%84.79M | 42.51%89.41M |
| -Selling and marketing expense | 7.05%160.42M | 9.77%50.16M | 9.60%40.56M | -16.40%31.62M | 29.83%38.08M | 26.93%149.86M | 6.55%45.7M | 2.73%37.01M | 38.91%37.83M | 145.98%29.33M |
| -General and administrative expense | 35.98%330.24M | 15.30%89.16M | 75.50%102.66M | 45.62%68.39M | 16.57%70.03M | -0.07%242.87M | -2.44%77.33M | 16.74%58.5M | -25.28%46.97M | 18.23%60.08M |
| Other operating expenses | ---- | ---- | --510K | ---- | -2,508.89%-1.08M | ---- | ---- | ---- | ---- | --45K |
| Total other operating income | 446.03%33.93M | 197.92%30.03M | ---- | -76.88%3.33M | ---- | -146.95%-9.81M | -385.41%-30.67M | 770.32%6.51M | 84.35%14.4M | ---- |
| Operating profit | 48.37%899.76M | 39.00%170.23M | -22.35%197.31M | 188.62%335.64M | 73.13%196.58M | 24.69%606.42M | -33.13%122.47M | 108.08%254.12M | 6.71%116.29M | 57.50%113.55M |
| Net non-operating interest income (expenses) | 5.67%42.26M | -52.71%8.89M | 967.47%13.23M | -9.02%12.11M | 20.96%8.03M | 363.81%39.99M | 155.20%18.81M | -54.13%1.24M | 1,553.17%13.31M | 1,350.09%6.64M |
| Non-operating interest income | -9.65%102.7M | -7.15%25.9M | -6.83%26M | -13.11%25.88M | -11.25%24.91M | 11.32%113.66M | 8.55%27.9M | -0.33%27.91M | 22.94%29.79M | 16.13%28.06M |
| Non-operating interest expense | -17.96%60.44M | 87.05%17.01M | -52.09%12.78M | -16.42%13.77M | -21.23%16.88M | 1,234.42%73.67M | 111.14%9.09M | 5.41%26.67M | -34.47%16.48M | -13.25%21.43M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -240.44%-179.55M | -257.52%-23.09M | -124.35%-46.45M | -348.67%-86.61M | 14.54%-23.41M | -102.12%-52.74M | 62.49%14.66M | 25.97%-20.71M | -125.40%-19.3M | -2,031.66%-27.39M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 5.72%17.58M | -193.59%-12.75M | 529.74%26.34M | 10.28%4.4M | -107.83%-403K | 1,022.89%16.63M | 126.06%13.63M | -119.99%-6.13M | -91.40%3.99M | -49.53%5.14M |
| Income before tax | 27.81%780.05M | -15.50%143.28M | -16.67%190.43M | 132.34%265.54M | 84.61%180.8M | 33.00%610.31M | 24.91%169.56M | 142.92%228.52M | -21.65%114.29M | 17.75%97.94M |
| Income tax | 36.14%262.45M | 41.12%51.29M | -31.29%57.89M | 181.57%99.81M | 45.50%53.46M | 31.00%192.78M | -8.60%36.34M | 112.59%84.24M | -12.08%35.45M | 36.12%36.74M |
| Net income | 23.97%517.6M | -30.95%91.99M | -8.14%132.54M | 110.21%165.73M | 108.09%127.34M | 33.95%417.53M | 38.79%133.22M | 165.00%144.28M | -25.31%78.84M | 8.93%61.2M |
| Net income continuous operations | 23.97%517.6M | -30.95%91.99M | -8.14%132.54M | 110.21%165.73M | 108.09%127.34M | 33.95%417.53M | 38.79%133.22M | 165.00%144.28M | -25.31%78.84M | 8.93%61.2M |
| Noncontrolling interests | 60.14%15.4M | 83.01%3.59M | 771.47%4.28M | -51.49%3.77M | 618.55%3.76M | 332.21%9.62M | 127.35%1.96M | 62.16%-638K | 1,305.24%7.77M | -87.96%523K |
| Net income attributable to the company | 23.11%502.2M | -32.65%88.41M | -11.50%128.26M | 127.89%161.96M | 103.69%123.58M | 29.15%407.91M | 27.25%131.26M | 158.17%144.92M | -32.31%71.07M | 17.04%60.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.11%502.2M | -32.65%88.41M | -11.50%128.26M | 127.89%161.96M | 103.69%123.58M | 29.15%407.91M | 27.25%131.26M | 158.17%144.92M | -32.31%71.07M | 17.04%60.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 23.00%0.0738 | -32.64%0.013 | -9.52%0.019 | 140.00%0.024 | 100.00%0.018 | 30.43%0.06 | 28.67%0.0193 | 162.50%0.021 | -33.33%0.01 | 12.50%0.009 |
| Diluted earnings per share | 23.00%0.0738 | -32.64%0.013 | -9.52%0.019 | 140.00%0.024 | 100.00%0.018 | 30.43%0.06 | 28.67%0.0193 | 162.50%0.021 | -33.33%0.01 | 12.50%0.009 |
| Dividend per share | 50.00%0.03 | 0.015 | 0 | 0.015 | 0 | 100.00%0.02 | 0 | 0.00%0.01 | 0 | 0.01 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.